Abstract
A multicenter (three centers) study compared MICs obtained by the Sensititre YeastOne Colorimetric Antifungal plate to reference microdilution broth (NCCLS M27-A2 document) MICs of three new triazoles (posaconazole, ravuconazole, and voriconazole) and the echinocandin caspofungin acetate for 100 isolates of Candida spp. In addition, amphotericin B and fluconazole were tested as control drugs. Colorimetric MICs of caspofungin and amphotericin B corresponded to the first blue well (no growth), and MICs of the other agents corresponded to the first slightly purple or blue well. Two comparisons of MIC pairs by the two methods were evaluated: 24-h colorimetric MICs were compared to NCCLS MICs at 24 and at 48 h. The interlaboratory reproducibility of YeastOne and reference MICs was also examined. The best performance of the YeastOne plate was with 24-h MICs (overall, 95 to 99% agreement) for all the species and antifungal agents. These results suggest the potential value of the YeastOne plate for use in the clinical laboratory for the four new antifungal agents evaluated.
MeSH Terms
Antifungal Agents/pharmacology
Candida/drug effects,isolation & purification
Candidiasis
Caspofungin
Colorimetry/methods
Echinocandins
Humans
Lipopeptides
Microbial Sensitivity Tests/methods
Peptides/pharmacology
Peptides, Cyclic
Reproducibility of Results
Sensitivity and Specificity
Triazoles/pharmacology
Chemicals
Antifungal Agents
Echinocandins
Lipopeptides
Peptides
Peptides, Cyclic
Triazoles
Caspofungin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Pfaller M
Messer S A
Knapp C C
Holliday N
Killian S B
References (11)
11 references, click to expand
-
Quality control limits for broth microdilution susceptibility tests of ten antifungal agents.
J Clin Microbiol. 2000 Sep;38(9):3457-9
PMID: 10970403
-
In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.
Mycopathologia. 2001;150(3):101-15
PMID: 11469757
-
Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.
J Clin Microbiol. 2002 Mar;40(3):852-6
PMID: 11880404
-
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.
Antimicrob Agents Chemother. 2002 Jun;46(6):1723-7
PMID: 12019081
-
Comparison of caspofungin and amphotericin B for invasive candidiasis.
N Engl J Med. 2002 Dec 19;347(25):2020-9
PMID: 12490683
-
Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms.
J Clin Microbiol. 1999 Mar;37(3):591-5
PMID: 9986817
-
Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose.
J Clin Microbiol. 1996 Apr;34(4):848-52
PMID: 8815095
-
In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens.
J Clin Microbiol. 1998 Jan;36(1):198-202
PMID: 9431946
-
Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.
J Clin Microbiol. 1998 Oct;36(10):2950-6
PMID: 9738049
-
Multisite reproducibility of MIC results by the Sensititre YeastOne colorimetric antifungal susceptibility panel.
Diagn Microbiol Infect Dis. 1998 Aug;31(4):543-7
PMID: 9764393
-
Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests.
J Clin Microbiol. 1992 Dec;30(12):3138-45
PMID: 1452697